|
Phase III Randomized Study of Gemcitabine Hydrochloride and Cisplatin With
Versus Without Bevacizumab in Patients With Advanced Transitional Cell
Carcinoma of the Urinary Tract
CALGB 90601
(MBMC Contact:
Chris Joyce 314-996-5536)
Click
For Consent
***
***Available through CTSU
|